Tomasjord, Norway

Øystein Rekdal

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Tromsø, NO (2008 - 2012)
  • Tomasjord, NO (2007 - 2015)
  • Hvalstad, NO (2015)
  • Tromso, NO (2015 - 2017)
  • Billingstad, NO (2019)

Company Filing History:


Years Active: 2007-2019

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Øystein Rekdal: Innovator in Antimicrobial and Anti-Tumor Peptides

Introduction

Øystein Rekdal is a notable inventor based in Tomasjord, Norway. He has made significant contributions to the field of biochemistry, particularly in the development of peptides with therapeutic applications. With a total of 11 patents to his name, Rekdal's work focuses on innovative solutions for combating diseases such as lymphoma and infections.

Latest Patents

One of Rekdal's latest patents is centered around anti-lymphoma peptides. This invention provides a peptide that consists of 10 to 16 amino acids, featuring at least 8 cationic amino acids. These amino acids include side chains with either a guanidinium group or an amino group, ensuring that no more than 7 are consecutive. Additionally, the peptide contains 2 or 3 tryptophan residues that are not all consecutive. This invention also encompasses pharmaceutical compositions that utilize these peptides as anti-tumor agents, particularly for lymphoma treatment.

Another significant patent involves antimicrobial compounds. This invention describes a compound formula that includes cationic amino acids and an amino acid with a lipophilic R group. The R group is characterized by having 14-27 non-hydrogen atoms, and the compound is designed for therapeutic use as antimicrobial, anti-tumor, or anti-biofilm agents. The invention also includes formulations and solid supports that incorporate these compounds, highlighting their versatility in both therapeutic and non-therapeutic applications.

Career Highlights

Rekdal has worked with several prominent organizations, including Lytix Biopharma AS and the University of Tromsø—The Arctic University of Norway. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Throughout his career, Øystein Rekdal has collaborated with notable colleagues such as John Sigurd Svendsen and Wenche Stensen. These partnerships have further enriched his research endeavors and have led to innovative developments in his field.

Conclusion

Øystein Rekdal's contributions to the field of biochemistry through his innovative patents demonstrate his commitment to advancing therapeutic solutions. His work in developing anti-lymphoma and antimicrobial peptides showcases the potential for significant impact in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…